• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Isis Pharmaceuticals, Inc. (ISIS)

    -NasdaqGS
    68.51 Down 1.35(1.93%) Jan 30, 4:00PM EST
    |After Hours : 68.55 Up 0.04 (0.06%) Jan 30, 7:15PM EST
    Add to Portfolio
    Prev Close:69.86
    Open:69.50
    Bid:N/A
    Ask:71.40 x 100
    1y Target Est:63.60
    Beta:1.49
    Earnings Date:Feb 26 - Mar 2 (Est.)
    Day's Range:68.06 - 71.04
    52wk Range:22.25 - 75.24
    Volume:2,327,770
    Avg Vol (3m):3,119,720
    Market Cap:8.09B
    P/E (ttm):N/A
    EPS (ttm):-0.81
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ISISDown 1.93%8.09B
    ENZUp 0.64%140.97M
    GILDUp 0.62%158.15B
    SRPTDown 2.44%495.71M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):48.11
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.61
    Quarterly EPS Est (Dec-14) :0.01
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-4.97

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback